Literature DB >> 8067754

Tn924, a chromosome-borne transposon encoding high-level gentamicin resistance in Enterococcus faecalis.

L A Thal1, J W Chow, D B Clewell, M J Zervos.   

Abstract

Enterococcus faecalis SF350 is a clinical isolate from Winnipeg, Canada, with high-level (MIC > 2,000 micrograms/ml) gentamicin resistance. The genetic determinant for gentamicin resistance was located on the chromosome of SF350 and could be mobilized by a coresident conjugative plasmid, pYN120. Genetic and physical analyses showed that the gentamicin resistance determinant was located on a 27-kb transposable element which was designated Tn924.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8067754      PMCID： PMC188167          DOI： 10.1128/AAC.38.5.1152

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  27 in total

Review 1.  Resistance of enterococci to glycopeptides.

Authors:  P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

2.  Mobilization of the gentamicin resistance gene in Enterococcus faecalis.

Authors:  S L Hodel-Christian; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Nucleotide sequence analysis of IS256 from the Staphylococcus aureus gentamicin-tobramycin-kanamycin-resistance transposon Tn4001.

Authors:  M E Byrne; D A Rouch; R A Skurray
Journal:  Gene       Date:  1989-09-30       Impact factor: 3.688

Review 4.  High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology.

Authors:  J E Patterson; M J Zervos
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

5.  Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis.

Authors:  J E Patterson; B L Masecar; M J Zervos
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

6.  Two conjugation systems associated with Streptococcus faecalis plasmid pCF10: identification of a conjugative transposon that transfers between S. faecalis and Bacillus subtilis.

Authors:  P J Christie; R Z Korman; S A Zahler; J C Adsit; G M Dunny
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

7.  Streptococcus faecalis sex pheromone (cAM373) also produced by Staphylococcus aureus and identification of a conjugative transposon (Tn918).

Authors:  D B Clewell; F Y An; B A White; C Gawron-Burke
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

8.  Mobility of gentamicin resistance genes from staphylococci isolated in the United States: identification of Tn4031, a gentamicin resistance transposon from Staphylococcus epidermidis.

Authors:  W D Thomas; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

9.  Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256.

Authors:  D M Shlaes; A Bouvet; C Devine; J H Shlaes; S al-Obeid; R Williamson
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

10.  Complete nucleotide sequence of macrolide-lincosamide-streptogramin B-resistance transposon Tn917 in Streptococcus faecalis.

Authors:  J H Shaw; D B Clewell
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490
View more
  10 in total

1.  Structures, locations, and transfer frequencies of genetic elements conferring high-level gentamicin resistance in Enterococcus faecalis isolates in Greece.

Authors:  George L Daikos; George Bamias; Christos Kattamis; Marcus J Zervos; Joseph W Chow; George Christakis; George Petrikkos; Penelope Triantafyllopoulou; Helen Alexandrou; Vassiliki Syriopoulou
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

2.  Chromosomal gentamicin resistance transposon Tn3706 in Streptococcus agalactiae B128.

Authors:  T Horaud; G de Céspèdes; P Trieu-Cuot
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 3.  Diversity among multidrug-resistant enterococci.

Authors:  B E Murray
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

4.  A new high-level gentamicin resistance gene, aph(2'')-Id, in Enterococcus spp.

Authors:  S F Tsai; M J Zervos; D B Clewell; S M Donabedian; D F Sahm; J W Chow
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Characterization of antimicrobial resistance in enterococci of animal origin.

Authors:  L A Thal; J W Chow; R Mahayni; H Bonilla; M B Perri; S A Donabedian; J Silverman; S Taber; M J Zervos
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

6.  A novel gentamicin resistance gene in Enterococcus.

Authors:  J W Chow; M J Zervos; S A Lerner; L A Thal; S M Donabedian; D D Jaworski; S Tsai; K J Shaw; D B Clewell
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

7.  Diversity of structures carrying the high-level gentamicin resistance gene (aac6-aph2) in Enterococcus faecalis strains isolated in France.

Authors:  A Casetta; A B Hoï; G de Cespédès; T Horaud
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

8.  In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.

Authors:  Cong-Ran Li; Xin-Yi Yang; Ren-Hui Lou; Wei-Xin Zhang; Yue-Ming Wang; Min Yuan; Yi Li; Hui-Zhen Chen; Bin Hong; Cheng-Hang Sun; Li-Xun Zhao; Zhuo-Rong Li; Jian-Dong Jiang; Xue-Fu You
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

9.  Genetic diversity among Enterococcus faecalis.

Authors:  Shonna M McBride; Vincent A Fischetti; Donald J Leblanc; Robert C Moellering; Michael S Gilmore
Journal:  PLoS One       Date:  2007-07-04       Impact factor: 3.240

Review 10.  Competent but complex communication: The phenomena of pheromone-responsive plasmids.

Authors:  Amy J Sterling; William J Snelling; Patrick J Naughton; Nigel G Ternan; James S G Dooley
Journal:  PLoS Pathog       Date:  2020-04-02       Impact factor: 6.823
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.